Reported about 1 year ago
The FDA has approved Merck's new vaccine to protect adults from pneumonia. The vaccine aims to prevent pneumonia caused by a particular bacteria, especially affecting older adults and younger children. Merck's vaccine covers 21 strains, offering significant protection for individuals aged 65 and older, who are most at risk of serious illness or death from this disease. The CDC's recommendation on the vaccine is still awaited, as Merck seeks to address the market challenges it faces with the patent cliff of Kruta.
Source: YAHOO